These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30446997)

  • 1. Prostaglandin E
    Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
    Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
    Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induced sputum supernatant prostaglandin E2 during oral aspirin challenge of asthmatic patients with and without aspirin hypersensitivity and healthy controls--pilot study].
    Ignacak M; Celejewska-Wójcik N; Wójcik K; Sałapa K; Konduracka E; Sanak M; Tyrak K; Sładek K; Musiał J; Mastalerz L
    Przegl Lek; 2016; 73(2):93-6. PubMed ID: 27197430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
    Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
    Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
    Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
    Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma.
    Higashi N; Taniguchi M; Mita H; Osame M; Akiyama K
    Clin Exp Allergy; 2002 Oct; 32(10):1484-90. PubMed ID: 12372129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
    Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E
    Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].
    Förster-Ruhrmann U; Behrbohm W; Pierchalla G; Szczepek AJ; Fluhr JW; Olze H
    HNO; 2019 Aug; 67(8):620-627. PubMed ID: 31069402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
    Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
    Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
    J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between TMEM196 polymorphisms and NSAID-exacerbated respiratory disease in asthma.
    Lee JU; Chang HS; Baek DG; Shin HD; Park CS; Park JS
    Pharmacogenet Genomics; 2019 Jun; 29(4):69-75. PubMed ID: 30694883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.
    Higashi A; Kumlin M; Higashi N; Daham K; Gaber F; Lindeberg A; James A; Skedinger M; Delin I; Gyllfors P; Dahlén SE; Dahlén B
    Int Arch Allergy Immunol; 2012; 158(3):299-306. PubMed ID: 22398682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P; Armetti L; Gambaro G; Pieroni MG; Refini RM; Sala A; Vaghi A; Folco GC; Bianco S; Robuschi M
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria.
    Doña I; Jurado-Escobar R; Perkins JR; Ayuso P; Plaza-Serón MC; Pérez-Sánchez N; Campo P; Bogas-Herrera G; Bartra J; Torres MJ; Sanak M; Cornejo-García JA
    Allergy; 2019 Jun; 74(6):1135-1144. PubMed ID: 30667070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.